103 related articles for article (PubMed ID: 17727796)
1. Effect of medium pH on the cytotoxicity of hydrophilic statins.
Kobayashi M; Kagawa T; Takano R; Itagaki S; Hirano T; Iseki K
J Pharm Pharm Sci; 2007; 10(3):332-9. PubMed ID: 17727796
[TBL] [Abstract][Full Text] [Related]
2. Preventive effects of bicarbonate on cerivastatin-induced apoptosis.
Kobayashi M; Kaido F; Kagawa T; Itagaki S; Hirano T; Iseki K
Int J Pharm; 2007 Aug; 341(1-2):181-8. PubMed ID: 17553641
[TBL] [Abstract][Full Text] [Related]
3. Statin-induced myopathy in the rat: relationship between systemic exposure, muscle exposure and myopathy.
Sidaway J; Wang Y; Marsden AM; Orton TC; Westwood FR; Azuma CT; Scott RC
Xenobiotica; 2009 Jan; 39(1):90-8. PubMed ID: 19219751
[TBL] [Abstract][Full Text] [Related]
4. Effects of rosuvastatin and pitavastatin on ischemia-induced myocardial stunning in dogs.
Satoh K; Takaguri A; Itagaki M; Kano S; Ichihara K
J Pharmacol Sci; 2008 Apr; 106(4):593-9. PubMed ID: 18403900
[TBL] [Abstract][Full Text] [Related]
5. Human skeletal muscle drug transporters determine local exposure and toxicity of statins.
Knauer MJ; Urquhart BL; Meyer zu Schwabedissen HE; Schwarz UI; Lemke CJ; Leake BF; Kim RB; Tirona RG
Circ Res; 2010 Feb; 106(2):297-306. PubMed ID: 19940267
[TBL] [Abstract][Full Text] [Related]
6. Association between risk of myopathy and cholesterol-lowering effect: a comparison of all statins.
Kobayashi M; Chisaki I; Narumi K; Hidaka K; Kagawa T; Itagaki S; Hirano T; Iseki K
Life Sci; 2008 Apr; 82(17-18):969-75. PubMed ID: 18402982
[TBL] [Abstract][Full Text] [Related]
7. [Effects of acidification and alkalinization agents on statins-induced muscle toxicity].
Kobayashi M; Hidaka K; Chisaki I; Takahashi N; Ogura J; Itagaki S; Hirano T; Yamaguchi H; Iseki K
Yakugaku Zasshi; 2012; 132(5):609-15. PubMed ID: 22687697
[TBL] [Abstract][Full Text] [Related]
8. No significant effect of ABCB1 haplotypes on the pharmacokinetics of fluvastatin, pravastatin, lovastatin, and rosuvastatin.
Keskitalo JE; Kurkinen KJ; Neuvonen M; Backman JT; Neuvonen PJ; Niemi M
Br J Clin Pharmacol; 2009 Aug; 68(2):207-13. PubMed ID: 19694740
[TBL] [Abstract][Full Text] [Related]
9. Role of multi-drug resistance-associated protein-1 transporter in statin-induced myopathy.
Dorajoo Rs; Pereira BP; Yu Z; Gopalakrishnakone P; Leong CC; Wee A; Lee E
Life Sci; 2008 Apr; 82(15-16):823-30. PubMed ID: 18509883
[TBL] [Abstract][Full Text] [Related]
10. Analysis of five HMG-CoA reductase inhibitors-- atorvastatin, lovastatin, pravastatin, rosuvastatin and simvastatin: pharmacological, pharmacokinetic and analytical overview and development of a new method for use in pharmaceutical formulations analysis and in vitro metabolism studies.
Pasha MK; Muzeeb S; Basha SJ; Shashikumar D; Mullangi R; Srinivas NR
Biomed Chromatogr; 2006 Mar; 20(3):282-93. PubMed ID: 16143964
[TBL] [Abstract][Full Text] [Related]
11. Rosuvastatin: characterization of induced myopathy in the rat.
Westwood FR; Scott RC; Marsden AM; Bigley A; Randall K
Toxicol Pathol; 2008 Feb; 36(2):345-52. PubMed ID: 18362199
[TBL] [Abstract][Full Text] [Related]
12. Liver-specific distribution of rosuvastatin in rats: comparison with pravastatin and simvastatin.
Nezasa K; Higaki K; Matsumura T; Inazawa K; Hasegawa H; Nakano M; Koike M
Drug Metab Dispos; 2002 Nov; 30(11):1158-63. PubMed ID: 12386119
[TBL] [Abstract][Full Text] [Related]
13. Rosuvastatin: new preparation. Opt for statins with evidence of efficacy on clinical outcome.
Prescrire Int; 2004 Aug; 13(72):132-4. PubMed ID: 15532136
[TBL] [Abstract][Full Text] [Related]
14. Coadministration of dalcetrapib with pravastatin, rosuvastatin, or simvastatin: no clinically relevant drug-drug interactions.
Derks M; Abt M; Phelan M; Turnbull L; Meneses-Lorente G; Bech N; White AM; Parr G
J Clin Pharmacol; 2010 Oct; 50(10):1188-201. PubMed ID: 20489031
[TBL] [Abstract][Full Text] [Related]
15. Involvement of organic anion transporting polypeptides in the toxicity of hydrophilic pravastatin and lipophilic fluvastatin in rat skeletal myofibres.
Sakamoto K; Mikami H; Kimura J
Br J Pharmacol; 2008 Aug; 154(7):1482-90. PubMed ID: 18500364
[TBL] [Abstract][Full Text] [Related]
16. Different effects of statins on induction of diabetes mellitus: an experimental study.
Zhao W; Zhao SP
Drug Des Devel Ther; 2015; 9():6211-23. PubMed ID: 26648697
[TBL] [Abstract][Full Text] [Related]
17. Rosuvastatin promotes osteoblast differentiation and regulates SLCO1A1 transporter gene expression in MC3T3-E1 cells.
Monjo M; Rubert M; Ellingsen JE; Lyngstadaas SP
Cell Physiol Biochem; 2010; 26(4-5):647-56. PubMed ID: 21063102
[TBL] [Abstract][Full Text] [Related]
18. The effect of gemfibrozil on the pharmacokinetics of rosuvastatin.
Schneck DW; Birmingham BK; Zalikowski JA; Mitchell PD; Wang Y; Martin PD; Lasseter KC; Brown CD; Windass AS; Raza A
Clin Pharmacol Ther; 2004 May; 75(5):455-63. PubMed ID: 15116058
[TBL] [Abstract][Full Text] [Related]
19. The issue of statin safety: where do we stand?
Grundy SM
Circulation; 2005 Jun; 111(23):3016-9. PubMed ID: 15911705
[No Abstract] [Full Text] [Related]
20. Possible mechanisms underlying statin-induced skeletal muscle toxicity in L6 fibroblasts and in rats.
Itagaki M; Takaguri A; Kano S; Kaneta S; Ichihara K; Satoh K
J Pharmacol Sci; 2009 Jan; 109(1):94-101. PubMed ID: 19129682
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
